232 related articles for article (PubMed ID: 32454073)
1. Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
Shah B; Toprover M; Crittenden DB; Jeurling S; Pike VC; Krasnokutsky S; Xia Y; Fisher MC; Slobodnick A; Tenner CT; Katz SD; Pillinger MH
Can J Cardiol; 2020 Nov; 36(11):1722-1728. PubMed ID: 32454073
[TBL] [Abstract][Full Text] [Related]
2. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout.
Wang L; Sawhney M; Zhao Y; Carpio GR; Fonseca V; Shi L
Clin Ther; 2015 Jun; 37(6):1206-15. PubMed ID: 25857595
[TBL] [Abstract][Full Text] [Related]
3. Association of gout with CAD and effect of antigout therapy on CVD risk among gout patients.
Huang WS; Lin CL; Tsai CH; Chang KH
J Investig Med; 2020 Jun; 68(5):972-979. PubMed ID: 32098832
[TBL] [Abstract][Full Text] [Related]
4. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
5. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Crittenden DB; Lehmann RA; Schneck L; Keenan RT; Shah B; Greenberg JD; Cronstein BN; Sedlis SP; Pillinger MH
J Rheumatol; 2012 Jul; 39(7):1458-64. PubMed ID: 22660810
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.
Singh JA; Ramachandaran R; Yu S; Curtis JR
BMC Cardiovasc Disord; 2017 Mar; 17(1):76. PubMed ID: 28288564
[TBL] [Abstract][Full Text] [Related]
7. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
Kwon OC; Hong S; Ghang B; Kim YG; Lee CK; Yoo B
Am J Med; 2017 May; 130(5):583-587. PubMed ID: 28065770
[TBL] [Abstract][Full Text] [Related]
8. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.
Solomon DH; Liu CC; Kuo IH; Zak A; Kim SC
Ann Rheum Dis; 2016 Sep; 75(9):1674-9. PubMed ID: 26582823
[TBL] [Abstract][Full Text] [Related]
9. Update on colchicine, 2017.
Slobodnick A; Shah B; Krasnokutsky S; Pillinger MH
Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i4-i11. PubMed ID: 29272515
[TBL] [Abstract][Full Text] [Related]
10. Impact of allopurinol on risk of myocardial infarction.
Grimaldi-Bensouda L; Alpérovitch A; Aubrun E; Danchin N; Rossignol M; Abenhaim L; Richette P;
Ann Rheum Dis; 2015 May; 74(5):836-42. PubMed ID: 24395556
[TBL] [Abstract][Full Text] [Related]
11. Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis.
Wan H; Zeng L; Xiao R; Tang X; Shu Y; Shen S
Z Rheumatol; 2022 Aug; 81(6):501-506. PubMed ID: 35794279
[TBL] [Abstract][Full Text] [Related]
12. Association between colchicine use and the risk of dementia among patients with gout: A nationwide retrospective cohort study.
Chen PY; Tseng CC; Lee YT; Yip HT; Chang R; Wei JC
Int J Rheum Dis; 2024 May; 27(5):e15162. PubMed ID: 38720421
[TBL] [Abstract][Full Text] [Related]
13. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
Lin HC; Daimon M; Wang CH; Ho Y; Uang YS; Chiang SJ; Wang LH
Int J Cardiol; 2017 Apr; 233():85-90. PubMed ID: 28202260
[TBL] [Abstract][Full Text] [Related]
14. Nonobstructive coronary artery disease and risk of myocardial infarction.
Maddox TM; Stanislawski MA; Grunwald GK; Bradley SM; Ho PM; Tsai TT; Patel MR; Sandhu A; Valle J; Magid DJ; Leon B; Bhatt DL; Fihn SD; Rumsfeld JS
JAMA; 2014 Nov; 312(17):1754-63. PubMed ID: 25369489
[TBL] [Abstract][Full Text] [Related]
15. Gout can increase the risk of periodontal disease in Taiwan.
Chen HH; Ho CW; Hsieh MC; Chen CC; Hsu SP; Lin CL; Kao CH
Postgrad Med; 2020 Aug; 132(6):521-525. PubMed ID: 32298158
[No Abstract] [Full Text] [Related]
16. Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.
Kesselheim AS; Franklin JM; Kim SC; Seeger JD; Solomon DH
J Gen Intern Med; 2015 Nov; 30(11):1633-8. PubMed ID: 25855479
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Colchicine on Carotid Intima-Media Thickness: A Prospective Comparative Study.
Yilmaz E; Akay KH
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105580. PubMed ID: 33387888
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic Burden and Heart Failure After Myocardial Infarction.
Gerber Y; Weston SA; Enriquez-Sarano M; Manemann SM; Chamberlain AM; Jiang R; Roger VL
JAMA Cardiol; 2016 May; 1(2):156-62. PubMed ID: 27437886
[TBL] [Abstract][Full Text] [Related]
19. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.
McCarthy CP; Ibrahim NE; Lyass A; Li Y; Gaggin HK; Simon ML; Mukai R; Gandhi P; Kelly N; Motiwala SR; van Kimmenade RRJ; Massaro JM; D'Agostino RB; Januzzi JL
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29519811
[TBL] [Abstract][Full Text] [Related]
20. A new perspective on the pharmacoeconomics of colchicine.
Wertheimer AI; Davis MW; Lauterio TJ
Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]